menu
    • menu

    Company profile for Airway Therapeutics

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Airway Therapeutics was created in 2011 as a spin-out of Cincinnati Children’s Hospital Medical Center (CCHMC). Our goal is to bring innovation and expertise in protein therapeutics development for applications in the lung and pediatrics disciplines. We are committed to offering innovative solutions for serious and often rare, lung conditions and look forward to working closely with FDA and EMA to facilitate the development ...
    Airway Therapeutics was created in 2011 as a spin-out of Cincinnati Children’s Hospital Medical Center (CCHMC). Our goal is to bring innovation and expertise in protein therapeutics development for applications in the lung and pediatrics disciplines. We are committed to offering innovative solutions for serious and often rare, lung conditions and look forward to working closely with FDA and EMA to facilitate the development of AT-100. Each member of Airway’s management team brings more than 20 years of experience in academic and industrial research and development, drug development for rare diseases, etc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Airway TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11804 Conrey Road Suite 175 Cincinnati, Ohio 45249
    Telephone
    Telephone
    513.770.9630
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.airwaytherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Airway Therapeutics Appoints Joe Todisco To Board Of Directors
    Airway Therapeutics Appoints Joe Todisco To Board Of Directors

    13 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/airway-therapeutics-appoints-biopharma-leader-joe-todisco-to-board-of-directors-302739592.html

    PR NEWSWIRE
    13 Apr 2026
    Share Share
    Airway Gets EMA Approval for Zelpultide Study in Preterm Infants
    Airway Gets EMA Approval for Zelpultide Study in Preterm Infants

    12 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/airway-therapeutics-receives-european-medicines-agency-pediatric-committee-approval-for-zelpultide-alfas-study-plan-in-bronchopulmonary-dysplasia-for-very-preterm-infants-302527004.html

    PR NEWSWIRE
    12 Aug 2025
    Share Share
    Airway Therapeutics Launches Phase 3 Trial Of Zelpultide Alfa
    Airway Therapeutics Launches Phase 3 Trial Of Zelpultide Alfa

    15 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241015848986/en

    BUSINESSWIRE
    15 Oct 2024
    Share Share
    Airway Wins 2024 ATS Whitsett Award for Zelpultide Alfa
    Airway Wins 2024 ATS Whitsett Award for Zelpultide Alfa

    24 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240624070940/en

    BUSINESSWIRE
    24 Jun 2024
    Share Share
    Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa
    Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa

    05 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230605005067/en

    BUSINESSWIRE
    05 Jun 2023
    Share Share
    Airway Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa
    Airway Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa

    11 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230411005273/en

    BUSINESSWIRE
    11 Apr 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search